Data for: "Effect of malaria intermittent preventive treatment on SARS-CoV-2 seroprevalence and response to COVID-19 vaccination: longitudinal study nested within a randomised controlled trial"

5133 28 18825 2 110459 document 18825 SARS-CoV-2_POPVAC_B_data_codebook.html text/html 78db59b14d1a98f82ac5e5fc3e9596d7c335c98b189a11cd32e806d155634b91 SHA256 32012 2026-03-31 09:28:58 https://datacompass.lshtm.ac.uk/id/eprint/5133/2/SARS-CoV-2_POPVAC_B_data_codebook.html 5133 2 2 text/html Text en public cc_by_4

SARS-CoV-2_POPVAC_B_data_codebook.html

documentation indefinite Codebook for SARS-CoV-2 POPVAC B dataset 18826 4 110463 document 18826 SARS-CoV-2_POPVAC_B_data.csv text/plain 40ff5080eff0f94b57c5faf7c359d28a9d5a45671d55baae1d21a1494610b0ae SHA256 62 2026-03-31 09:30:09 https://datacompass.lshtm.ac.uk/id/eprint/5133/3/SARS-CoV-2_POPVAC_B_data.csv 5133 3 1 text/plain Dataset en staffonly datasharingagreement

SARS-CoV-2_POPVAC_B_data.csv

data indefinite SARS-CoV-2 POPVAC B dataset archive 559 disk0/00/00/51/33 2026-03-31 09:30:31 2026-03-31 09:51:45 2026-03-31 09:30:31 data_collection show Zirimenya Ludoviko 0000-0002-8296-7447 TRUE dfdf64063b138a70603f7d21a2b992fb Nassuuna Jacent TRUE Nayebare Doreen TRUE 1402f6914913e11d16243a4716557775 Baine Claire TRUE b024e9ce79560f8520f75b752445cecb Namutebi Milly TRUE 9c73bcb0a8b55d26c5bb92de5c153a5f Zziwa Christopher TRUE d74ece3275c84e8a26cee0c82cb85307 Nsubuga Denis TRUE 7f28b013e44ca55c15a1d943f3933840 Oduru Gloria TRUE 359c2a8bdfd9531cbf9399f1498f51a1 Akello-Ateng Florence TRUE Ninsiima Caroline TRUE 64ac80426dc5c84f51170f5509ad69d5 Mutebe Alex TRUE 3c5249e6752e477d11ee8f607daf6d58 Wajja Anne TRUE 3bb439be7ad3f3950fc315c54a7d4859 Kimuda Simon FALSE Natukunda Agnes 0000-0003-1156-201X TRUE e8f9d6363d29c2ef6e98e7ac6b81948a Nkurunungi Gyaviira 0000-0003-4062-9105 TRUE a48ee0eddf888813b8e342fdb4b32087 Serwanga Jennifer TRUE ebafe751bd2427e085d634b97967ea8e Elliott Alison 0000-0003-2818-9549 TRUE d9d54503b6d617709b2d9f1aaf480651 Webb Emily 0000-0002-4019-7456 TRUE 37be87b3e3571ab56ac10ff692e63cd3 London School of Hygiene & Tropical Medicine, London, United Kingdom MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda Data for: "Effect of malaria intermittent preventive treatment on SARS-CoV-2 seroprevalence and response to COVID-19 vaccination: longitudinal study nested within a randomised controlled trial" ITCR MRCUVRI Malaria SARS-CoV-2 COVID-19 vaccination Uganda Data access is restricted due to ethical conditions associated with the original study. Data will be made available for use in ethically-approved research, subject to a Data Transfer Agreement being arranged with the MRC/UVRI and LSHTM Uganda Research Unit. Applications are assessed by the PI (Professor Alison Elliott) with the POPVAC investigator team, in consultation with the POPVAC steering committee. This dataset contains longitudinal serological data from a study nested within the POPVAC B randomised, double-blind, placebo-controlled trial conducted among school-aged children in Uganda. It includes participant demographics, malaria infection status, and SARS-CoV-2 antibody measurements (spike and nucleocapsid IgG) collected at multiple timepoints before and after COVID-19 vaccination. Data capture exposure to intermittent preventive treatment with dihydroartemisinin–piperaquine or placebo, as well as COVID-19 vaccination status and timing. The dataset supports analyses of SARS-CoV-2 seroprevalence, antibody responses, and fold changes in relation to malaria chemoprevention and vaccination in a malaria-endemic setting. 2026-03-30 completed London School of Hygiene & Tropical Medicine 10.17037/DATA.00005133 Dataset London School of Hygiene & Tropical Medicine, London, United Kingdom XMAL XVAC Immunomodulation and Vaccines Group SelfAdministeredQuestionnaire Experiment.Laboratory restricted London, United Kingdom Medical Research Centre Medical Research Centre National Institute for Health and Care Research Science for Africa Foundation POPVAC programme POPVAC programme VAnguard CoHost Project Dataset Quantitative MR/R02118X/1 0.7 33.3 0.3 32.8 en 2021-05-25 2022-09-06 The effect of intermittent preventive treatment for malaria with dihydroartemisinin–piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial https://researchonline.lshtm.ac.uk/id/eprint/4674107/ POPVAC programme Medical Research Centre MR/R02118X/1 https://doi.org/10.13039/501100020643 POPVAC programme Medical Research Centre MC_PC_21034 https://doi.org/10.13039/501100020643 VAnguard National Institute for Health and Care Research NIHR134531 https://doi.org/10.13039/501100000272 CoHost Project Science for Africa Foundation GCA/SARSCov2-2-20-002 https://doi.org/10.13039/100031746